• 
  V. Camus, R. Houot, G. Brisou, B. Tessoulin, S. Bailly, et al.. Outcome of large B-cell lymphoma patients treated with tafasitamab plus lenalidomide either before or after CAR-T-cells.. Blood Advances, 2024, 8 (20), pp.5371-5381. ⟨10.1182/bloodadvances.2024013726⟩. ⟨hal-04708799⟩
• 
  Helio Fayolle, Nina Jehanno, Valerie Lauwers-Cances, Marie-Pierre Castex, Daniel Orbach, et al.. PET metabolic tumor volume as a new prognostic factor in childhood rhabdomyosarcoma. PLoS ONE, 2022, 17 (1), pp.e0261565. ⟨10.1371/journal.pone.0261565⟩. ⟨hal-04778301⟩
• 
  Sirine Amiri, Yirui Zhang, Andonis Gerardos, Cécile Sykes, Pierre Ronceray. Inferring geometrical dynamics of cell nucleus translocation. Physical Review Research, 2024, 6 (4), pp.043030. ⟨10.1103/physrevresearch.6.043030⟩. ⟨hal-04778056⟩
• 
  Modou Ndiaye, Emma Caillet, Svetlana Eliseeva, Thibaut Masson, Luke Marchetti, et al.. Synthesis, Luminescence and Relaxometric Properties of Macrocyclic Lanthanide Complexes Appended with an Imidazothiadiazole, a Heterocyclic Bioactive Scaffold. European Journal of Inorganic Chemistry, 2024, 27 (7), ⟨10.1002/ejic.202300648⟩. ⟨hal-04634117⟩
• 
  Ryszard Wimmer. Migration of neural stem cells during human neocortical development. Cancer. Université Paris sciences et lettres, 2024. English. ⟨NNT : 2024UPSLS016⟩. ⟨tel-04777743⟩
• 
  Didier Decaudin, Fariba Némati, Vesnie Etienne, Harry Ahnine, Quentin Peretti, et al.. Evaluation of Combined Chemotherapy and Genomic-Driven Targeted Therapy in Patient-Derived Xenografts Identifies New Therapeutic Approaches in Squamous Non-Small-Cell Lung Cancer Patients. Cancers, 2024, 16 (16), ⟨10.3390/cancers16162785⟩. ⟨hal-04724615⟩
• 
  Pierre Etienne Gabriel, Morgan Rouprêt, Thomas Seisen, Géraldine Cancel-Tassin, François Audenet, et al.. A collaborative review of the microsatellite instability/deficient mismatch repair phenotype in patients with upper tract urothelial carcinoma. BJU International, 2024, ⟨10.1111/bju.16405⟩. ⟨hal-04724613⟩
• 
  Laszlo Radnai, Erica J Young, Carlos Kikuti, Madalyn Hafenbreidel, Rebecca F Stremel, et al.. Development of Clinically Viable Non-Muscle Myosin II Small Molecule Inhibitors with Broad Therapeutic Potential. 2024. ⟨hal-04775437⟩
• 
  Mariette Bonnet, Chun Hui Sun, Jost Enninga, Anne Houdusse, Guy Tran van Nhieu. Ca 2+ regulation of Myosin II and Myosin VI during rupture of the Shigella -containing vacuole. 2024. ⟨hal-04775436⟩
• 
  Florian E C Blanc, Anne Houdusse, Marco Cecchini. A weak coupling mechanism for the early steps of the recovery stroke of myosin VI: A free energy simulation and string method analysis. PLoS Computational Biology, 2024, 20 (4), pp.e1012005. ⟨10.1371/journal.pcbi.1012005⟩. ⟨hal-04775430⟩
• 
  James J Hartman, Darren T Hwee, Julien Robert-Paganin, Chihyuan Chuang, Eva R Chin, et al.. Aficamten is a small-molecule cardiac myosin inhibitor designed to treat hypertrophic cardiomyopathy. Nature Cardiovascular Research, 2024, 3 (8), pp.1003-1016. ⟨10.1038/s44161-024-00505-0⟩. ⟨hal-04775429⟩
• 
  James Spudich, Neha Nandwani, Julien Robert-Paganin, Anne Houdusse, Kathleen Ruppel. Reassessing the unifying hypothesis for hypercontractility caused by myosin mutations in hypertrophic cardiomyopathy. EMBO Journal, 2024, 43 (19), pp.4139-4155. ⟨10.1038/s44318-024-00199-x⟩. ⟨hal-04775427⟩
• 
  Monalisa Mukherjea, M Yusuf Ali, Carlos Kikuti, Daniel Safer, Zhaohui Yang, et al.. Myosin VI Must Dimerize and Deploy Its Unusual Lever Arm in Order to Perform Its Cellular Roles. Cell Reports, 2014, 8 (5), ⟨10.1016/j.celrep.2014.07.041⟩. ⟨hal-04775412⟩
• 
  Olena Pylypenko, Hussein Hammich, I-Mei Yu, Anne Houdusse. Rab GTPases and their interacting protein partners: Structural insights into Rab functional diversity. Small GTPases, 2018, 9 (1-2), pp.22-48. ⟨10.1080/21541248.2017.1336191⟩. ⟨hal-02349559⟩
• 
  Constanze Erdmann, Roua Hassoun, Sebastian Schmitt, Carlos Kikuti, Anne Houdusse, et al.. Integration of Cardiac Actin Mutants Causing Hypertrophic (p.A295S) and Dilated Cardiomyopathy (p.R312H and p.E361G) into Cellular Structures. Antioxidants , 2021, Oxidative Stress in Cardiovascular Diseases, 10 (7), pp.1082. ⟨10.3390/antiox10071082⟩. ⟨hal-03453111⟩
• 
  Sara Bizzotto, Ana Uzquiano, Florent Dingli, Dmitry Ershov, Anne Houllier, et al.. Eml1 loss impairs apical progenitor spindle length and soma shape in the developing cerebral cortex. Scientific Reports, 2017, 7 (1), pp.17308. ⟨10.1038/s41598-017-15253-4⟩. ⟨hal-03825519⟩
• 
  Herschel Dhekne, Olena Pylypenko, Arend Overeem, Rosaria Ferreira, K. Joeri van Der Velde, et al.. MYO5B , STX3 , and STXBP2 mutations reveal a common disease mechanism that unifies a subset of congenital diarrheal disorders: A mutation update. Human Mutation, 2018, 39 (3), pp.333-344. ⟨10.1002/humu.23386⟩. ⟨hal-02349537⟩
• 
  Yao Xiang, Jorge Mata-Garrido, Yuanji Fu, Christophe Desterke, Eric Batsché, et al.. CBX3 antagonizes IFNγ/STAT1/PD-L1 axis to modulate colon inflammation and CRC chemosensitivity. EMBO Molecular Medicine, 2024, 16 (6), pp.1404-1426. ⟨10.1038/s44321-024-00066-6⟩. ⟨hal-04774471⟩
• 
  Noémie Huchet, Nicolas Penel, Sylvie Bonvalot, Juliette Thariat, Françoise Ducimetière, et al.. Handling missing covariates in observational studies: an illustration with the assessment of prognostic factors of survival outcomes in soft-tissue or visceral sarcomas in irradiated fields (SIF). Therapeutic Advances in Medical Oncology, 2024, 16, ⟨10.1177/17588359231220999⟩. ⟨hal-04425867⟩
• 
  Olivier Bylicki, Florian Guisier, Arnaud Scherpereel, Catherine Daniel, Aurélie Swalduz, et al.. Real-World efficacy and safety of combination nivolumab plus ipilimumab for Untreated, Unresectable, pleural Mesothelioma: The Meso-Immune (GFPC 04–2021) trial. Lung Cancer, 2024, 194, pp.107866. ⟨10.1016/j.lungcan.2024.107866⟩. ⟨hal-04751314⟩

4 226

3 747